We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FORM:NASDAQFormFactor, Inc. Analysis

Data as of 2026-06-09 - not real-time

$120.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

FormFactor, Inc. (FORM) is trading around $120, just below its 20‑day SMA of $125.5 and 50‑day SMA of $128.4, while the 200‑day SMA sits near $78, indicating a long‑term uptrend but short‑term weakness. Technical indicators are mixed: the RSI at 45 suggests neutral momentum, the MACD line is below its signal (bearish), and volume is on a decreasing trend, all pointing to a cautious near‑term outlook. Fundamentally, the company posted a 32% revenue growth year‑over‑year with a solid gross margin of 42% and operating margin of 17.7%, and it generates positive operating cash flow despite a modest free‑cash‑flow shortfall. However, valuation metrics are extreme – a trailing P/E of 138x versus an industry average of 36x, a price‑to‑book of 8.9x, and a DCF‑derived fair value of roughly $47, implying the stock is significantly overvalued at current levels. Analyst consensus remains a “Buy” with a median target near $155, reflecting confidence in long‑term growth despite the pricing premium. The company’s beta of over 2 and 30‑day volatility exceeding 80% add considerable market risk, while its exposure to global semiconductor supply chains introduces moderate geographic and regulatory uncertainties. In summary, FORM offers compelling growth fundamentals but is priced for perfection, making short‑term caution advisable while the longer horizon may justify a selective buy stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Decreasing trading volume
  • Price hovering just above recent support

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 32% YoY revenue growth
  • Robust gross and operating margins
  • Positive operating cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular demand for advanced semiconductor test equipment
  • Diversified product portfolio across probe cards and systems
  • Strategic positioning in emerging technologies such as quantum and AI chips

Key Metrics & Analysis

Financial Health

Revenue Growth32.00%
Profit Margin8.14%
P/E Ratio138.4
ROE6.75%
ROA5.15%
Debt/Equity3.01
P/B Ratio8.9
Op. Cash Flow$136.8M
Free Cash Flow$-566875
Industry P/E35.8

Technical Analysis

TrendNeutral
RSI45.2
Support$112.31
Resistance$146.00
MA 20$125.55
MA 50$128.44
MA 200$77.84
MACDBearish
VolumeDecreasing
Fear & Greed Index86.11

Valuation

Fair Value$47.32
Target Price$144.67
Upside/Downside20.18%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.14
Volatility80.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.